Loading…
Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection
In conclusion, we presented a rare case of ILD associated with IM therapy in a patient with GIST. It is important to have a high index of suspicion for this rare pulmonary toxicity when patients, in particular with preexisting lung disease, have unexplained lung infiltrates regardless of pulmonary s...
Saved in:
| Published in: | The Korean journal of internal medicine 2015, 30(4), , pp.550-553 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c358t-46c1f761dad1493fb0e4d7dabf53a6ef7e9d833dc01d1b492e4dbde6299ed0b13 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c358t-46c1f761dad1493fb0e4d7dabf53a6ef7e9d833dc01d1b492e4dbde6299ed0b13 |
| container_end_page | 553 |
| container_issue | 4 |
| container_start_page | 550 |
| container_title | The Korean journal of internal medicine |
| container_volume | 30 |
| creator | Lee, Na-Ri Jang, Ji Won Kim, Hee Sun Yhim, Ho-Young |
| description | In conclusion, we presented a rare case of ILD associated with IM therapy in a patient with GIST. It is important to have a high index of suspicion for this rare pulmonary toxicity when patients, in particular with preexisting lung disease, have unexplained lung infiltrates regardless of pulmonary symptoms if they are receiving the IM. The early evaluation with chest computed tomography and prompt withdrawal of IM with or without the use of corticosteroid is needed to avoid further detrimental effects of the drug. Furthermore, prospective study is needed to investigate the incidence of IM-induced ILD in patients with prior history of M.
tuberculosis infection. KCI Citation Count: 4 |
| doi_str_mv | 10.3904/kjim.2015.30.4.550 |
| format | article |
| fullrecord | <record><control><sourceid>pubmed_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_707493</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>26161025</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-46c1f761dad1493fb0e4d7dabf53a6ef7e9d833dc01d1b492e4dbde6299ed0b13</originalsourceid><addsrcrecordid>eNpVkctqHDEQRUVIiCdOfiCLoGU23Sk9Wj29CRiTx4BNwNhroadHnu7WIKkThvx8NJ7ExKta3DqnKC5C7wm0bAD-afcQppYC6VoGLW-7Dl6gFQXoGiH4-iVaEUpFwxiwM_Qm5wcA0cOavUZnVBBBgHYr9HszqRLmoPHk8mFUxTVhtotxFoe5uJRLKEGNeFzme2xDdiq7mmCF95Vzc8G_QtnifQox4W3IJaYDjh5fH0zUylRDWCZcFu2SWcaYQ660d6aEOL9Fr7was3v3d56ju69fbi-_N1c_vm0uL64aw7p1abgwxPeCWGUJH5jX4LjtrdK-Y0o437vBrhmzBoglmg-0xto6QYfBWdCEnaOPJ--cvNyZIKMKj_M-yl2SFze3G9lDX9119fNpdb_oyVlTH0xqlPW9SaXDI_g8mcO2an5KzoeecVEF9CQwKeacnH9iCchja_LYmjy2JhlILmtrFfrw_9Un5F9N7A_akpmu</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection</title><source>PubMed Central</source><creator>Lee, Na-Ri ; Jang, Ji Won ; Kim, Hee Sun ; Yhim, Ho-Young</creator><creatorcontrib>Lee, Na-Ri ; Jang, Ji Won ; Kim, Hee Sun ; Yhim, Ho-Young</creatorcontrib><description>In conclusion, we presented a rare case of ILD associated with IM therapy in a patient with GIST. It is important to have a high index of suspicion for this rare pulmonary toxicity when patients, in particular with preexisting lung disease, have unexplained lung infiltrates regardless of pulmonary symptoms if they are receiving the IM. The early evaluation with chest computed tomography and prompt withdrawal of IM with or without the use of corticosteroid is needed to avoid further detrimental effects of the drug. Furthermore, prospective study is needed to investigate the incidence of IM-induced ILD in patients with prior history of M.
tuberculosis infection. KCI Citation Count: 4</description><identifier>ISSN: 1226-3303</identifier><identifier>EISSN: 2005-6648</identifier><identifier>DOI: 10.3904/kjim.2015.30.4.550</identifier><identifier>PMID: 26161025</identifier><language>eng</language><publisher>Korea (South): The Korean Association of Internal Medicine</publisher><subject>Adult ; Antineoplastic Agents - adverse effects ; Antitubercular Agents - therapeutic use ; Biopsy ; Female ; Gastrointestinal Stromal Tumors - drug therapy ; Gastrointestinal Stromal Tumors - pathology ; Gastrointestinal Stromal Tumors - surgery ; Humans ; Imatinib Mesylate - adverse effects ; Letter to the Editor ; Lung Diseases, Interstitial - chemically induced ; Lung Diseases, Interstitial - diagnosis ; Mycobacterium tuberculosis - isolation & purification ; Protein Kinase Inhibitors - adverse effects ; Rectal Neoplasms - drug therapy ; Rectal Neoplasms - pathology ; Rectal Neoplasms - surgery ; Tomography, X-Ray Computed ; Tuberculosis, Pulmonary - diagnosis ; Tuberculosis, Pulmonary - drug therapy ; Tuberculosis, Pulmonary - microbiology ; 내과학</subject><ispartof>The Korean Journal of Internal Medicine, 2015, 30(4), , pp.550-553</ispartof><rights>Copyright © 2015 The Korean Association of Internal Medicine 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-46c1f761dad1493fb0e4d7dabf53a6ef7e9d833dc01d1b492e4dbde6299ed0b13</citedby><cites>FETCH-LOGICAL-c358t-46c1f761dad1493fb0e4d7dabf53a6ef7e9d833dc01d1b492e4dbde6299ed0b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497346/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497346/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26161025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002012543$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Na-Ri</creatorcontrib><creatorcontrib>Jang, Ji Won</creatorcontrib><creatorcontrib>Kim, Hee Sun</creatorcontrib><creatorcontrib>Yhim, Ho-Young</creatorcontrib><title>Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection</title><title>The Korean journal of internal medicine</title><addtitle>Korean J Intern Med</addtitle><description>In conclusion, we presented a rare case of ILD associated with IM therapy in a patient with GIST. It is important to have a high index of suspicion for this rare pulmonary toxicity when patients, in particular with preexisting lung disease, have unexplained lung infiltrates regardless of pulmonary symptoms if they are receiving the IM. The early evaluation with chest computed tomography and prompt withdrawal of IM with or without the use of corticosteroid is needed to avoid further detrimental effects of the drug. Furthermore, prospective study is needed to investigate the incidence of IM-induced ILD in patients with prior history of M.
tuberculosis infection. KCI Citation Count: 4</description><subject>Adult</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antitubercular Agents - therapeutic use</subject><subject>Biopsy</subject><subject>Female</subject><subject>Gastrointestinal Stromal Tumors - drug therapy</subject><subject>Gastrointestinal Stromal Tumors - pathology</subject><subject>Gastrointestinal Stromal Tumors - surgery</subject><subject>Humans</subject><subject>Imatinib Mesylate - adverse effects</subject><subject>Letter to the Editor</subject><subject>Lung Diseases, Interstitial - chemically induced</subject><subject>Lung Diseases, Interstitial - diagnosis</subject><subject>Mycobacterium tuberculosis - isolation & purification</subject><subject>Protein Kinase Inhibitors - adverse effects</subject><subject>Rectal Neoplasms - drug therapy</subject><subject>Rectal Neoplasms - pathology</subject><subject>Rectal Neoplasms - surgery</subject><subject>Tomography, X-Ray Computed</subject><subject>Tuberculosis, Pulmonary - diagnosis</subject><subject>Tuberculosis, Pulmonary - drug therapy</subject><subject>Tuberculosis, Pulmonary - microbiology</subject><subject>내과학</subject><issn>1226-3303</issn><issn>2005-6648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVkctqHDEQRUVIiCdOfiCLoGU23Sk9Wj29CRiTx4BNwNhroadHnu7WIKkThvx8NJ7ExKta3DqnKC5C7wm0bAD-afcQppYC6VoGLW-7Dl6gFQXoGiH4-iVaEUpFwxiwM_Qm5wcA0cOavUZnVBBBgHYr9HszqRLmoPHk8mFUxTVhtotxFoe5uJRLKEGNeFzme2xDdiq7mmCF95Vzc8G_QtnifQox4W3IJaYDjh5fH0zUylRDWCZcFu2SWcaYQ660d6aEOL9Fr7was3v3d56ju69fbi-_N1c_vm0uL64aw7p1abgwxPeCWGUJH5jX4LjtrdK-Y0o437vBrhmzBoglmg-0xto6QYfBWdCEnaOPJ--cvNyZIKMKj_M-yl2SFze3G9lDX9119fNpdb_oyVlTH0xqlPW9SaXDI_g8mcO2an5KzoeecVEF9CQwKeacnH9iCchja_LYmjy2JhlILmtrFfrw_9Un5F9N7A_akpmu</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Lee, Na-Ri</creator><creator>Jang, Ji Won</creator><creator>Kim, Hee Sun</creator><creator>Yhim, Ho-Young</creator><general>The Korean Association of Internal Medicine</general><general>대한내과학회</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>ACYCR</scope></search><sort><creationdate>20150701</creationdate><title>Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection</title><author>Lee, Na-Ri ; Jang, Ji Won ; Kim, Hee Sun ; Yhim, Ho-Young</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-46c1f761dad1493fb0e4d7dabf53a6ef7e9d833dc01d1b492e4dbde6299ed0b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antitubercular Agents - therapeutic use</topic><topic>Biopsy</topic><topic>Female</topic><topic>Gastrointestinal Stromal Tumors - drug therapy</topic><topic>Gastrointestinal Stromal Tumors - pathology</topic><topic>Gastrointestinal Stromal Tumors - surgery</topic><topic>Humans</topic><topic>Imatinib Mesylate - adverse effects</topic><topic>Letter to the Editor</topic><topic>Lung Diseases, Interstitial - chemically induced</topic><topic>Lung Diseases, Interstitial - diagnosis</topic><topic>Mycobacterium tuberculosis - isolation & purification</topic><topic>Protein Kinase Inhibitors - adverse effects</topic><topic>Rectal Neoplasms - drug therapy</topic><topic>Rectal Neoplasms - pathology</topic><topic>Rectal Neoplasms - surgery</topic><topic>Tomography, X-Ray Computed</topic><topic>Tuberculosis, Pulmonary - diagnosis</topic><topic>Tuberculosis, Pulmonary - drug therapy</topic><topic>Tuberculosis, Pulmonary - microbiology</topic><topic>내과학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Na-Ri</creatorcontrib><creatorcontrib>Jang, Ji Won</creatorcontrib><creatorcontrib>Kim, Hee Sun</creatorcontrib><creatorcontrib>Yhim, Ho-Young</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>The Korean journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Na-Ri</au><au>Jang, Ji Won</au><au>Kim, Hee Sun</au><au>Yhim, Ho-Young</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection</atitle><jtitle>The Korean journal of internal medicine</jtitle><addtitle>Korean J Intern Med</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>30</volume><issue>4</issue><spage>550</spage><epage>553</epage><pages>550-553</pages><issn>1226-3303</issn><eissn>2005-6648</eissn><abstract>In conclusion, we presented a rare case of ILD associated with IM therapy in a patient with GIST. It is important to have a high index of suspicion for this rare pulmonary toxicity when patients, in particular with preexisting lung disease, have unexplained lung infiltrates regardless of pulmonary symptoms if they are receiving the IM. The early evaluation with chest computed tomography and prompt withdrawal of IM with or without the use of corticosteroid is needed to avoid further detrimental effects of the drug. Furthermore, prospective study is needed to investigate the incidence of IM-induced ILD in patients with prior history of M.
tuberculosis infection. KCI Citation Count: 4</abstract><cop>Korea (South)</cop><pub>The Korean Association of Internal Medicine</pub><pmid>26161025</pmid><doi>10.3904/kjim.2015.30.4.550</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1226-3303 |
| ispartof | The Korean Journal of Internal Medicine, 2015, 30(4), , pp.550-553 |
| issn | 1226-3303 2005-6648 |
| language | eng |
| recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_707493 |
| source | PubMed Central |
| subjects | Adult Antineoplastic Agents - adverse effects Antitubercular Agents - therapeutic use Biopsy Female Gastrointestinal Stromal Tumors - drug therapy Gastrointestinal Stromal Tumors - pathology Gastrointestinal Stromal Tumors - surgery Humans Imatinib Mesylate - adverse effects Letter to the Editor Lung Diseases, Interstitial - chemically induced Lung Diseases, Interstitial - diagnosis Mycobacterium tuberculosis - isolation & purification Protein Kinase Inhibitors - adverse effects Rectal Neoplasms - drug therapy Rectal Neoplasms - pathology Rectal Neoplasms - surgery Tomography, X-Ray Computed Tuberculosis, Pulmonary - diagnosis Tuberculosis, Pulmonary - drug therapy Tuberculosis, Pulmonary - microbiology 내과학 |
| title | Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T09%3A38%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Imatinib%20mesylate-induced%20interstitial%20lung%20disease%20in%20a%20patient%20with%20prior%20history%20of%20Mycobacterium%20tuberculosis%20infection&rft.jtitle=The%20Korean%20journal%20of%20internal%20medicine&rft.au=Lee,%20Na-Ri&rft.date=2015-07-01&rft.volume=30&rft.issue=4&rft.spage=550&rft.epage=553&rft.pages=550-553&rft.issn=1226-3303&rft.eissn=2005-6648&rft_id=info:doi/10.3904/kjim.2015.30.4.550&rft_dat=%3Cpubmed_nrf_k%3E26161025%3C/pubmed_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c358t-46c1f761dad1493fb0e4d7dabf53a6ef7e9d833dc01d1b492e4dbde6299ed0b13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/26161025&rfr_iscdi=true |